Human Factor VII (Factor 7) Deficient Serum

<strong>Human Factor VII (Factor 7) Deficient Serum</strong>_x000D_ <strong>Catalog number:</strong> B2015450_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> N/A_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Coagulation Factor VII, Coagulation Factor 7, F7, FVII, Eptacog alfa, FA7, OTTHUMP00000018733, OTTHUMP00000018734, Proconvertin, Serum Prothrombin Conversion Accelerator, SPCA_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Mitry RR, Hughes RD, Dhawan A. Hepatocyte transplantation J Clin Exp Hepatol. 2011 Sep;1(2):109-14._x000D_ 2: Girolami A, Cosi E, Santarossa C, Ferrari S, Luigia Randi M. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII Semin Thromb Hemost. 2015 Jun;41(4):366-73._x000D_ 3: Stephan F, Marsman G, Bakker LM, Bulder I, Stavenuiter F, Aarden LA, Zeerleder S. Cooperation of factor VII-activating protease and serum DNase I in the release of nucleosomes from necrotic cells Arthritis Rheumatol. 2014 Mar;66(3):686-93._x000D_ 4: Mancuso ME, Mahlangu JN, Pipe SW. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing Lancet. 2021 Feb 13;397(10274):630-640._x000D_ 5: Silveira A. Postprandial triglycerides and blood coagulation Exp Clin Endocrinol Diabetes. 2001;109(4):S527-32._x000D_ 6: Kiykim E, Zubarioglu T, Cansever MS, Celkan T, Häberle J, Aktuglu Zeybek AC. Coagulation Disturbances in Patients with Argininemia Acta Haematol. 2018;140(4):221-225._x000D_ 7: Gorkom BL, Holme PA, Joch C, Rogosch T, Feussner A, McKeand W, Roberts J, van Heerde W. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency Hematology. 2020 Dec;25(1):17-25._x000D_ 8: BONNIN JA, HICKS ND, INNIS MD, SIMPSON DA. Multiple congenital coagulation deficiencies J Clin Pathol. 1960 Jul;13(4):311-4._x000D_ 9: Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM. Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein Thromb Res. 1992 Nov 1;68(3):283-93._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/234996">10: Saito H, Ratnoff OD. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems J Lab Clin Med. 1975 Mar;85(3):405-15.</a>_x000D_ _x000D_ <strong>Products Related to Human Factor VII (Factor 7) Deficient Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>